New

Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →

Advertisement
ETF Central logo
Advertisement

XHSvsPBEETF Comparison

ETF 1
XHS

SPDR S&P Health Care Services ETF

This fund is part of
US Health Care
-0.51%
Full XHS fund page
VS
ETF 2
PBE

Invesco Dynamic Biotechnology & Genome ETF

This fund is part of
BioTech & Genomics
-0.26%
Full PBE fund page

SPDR S&P Health Care Services ETF (XHS) belongs to the US Health Care segment. Invesco Dynamic Biotechnology & Genome ETF (PBE) is part of the BioTech & Genomics segment. Both ETFs have the same top 3 sector exposures: and Health Care. XHS is less expensive with a Total Expense Ratio (TER) of 0.35%, versus 0.58% for PBE. XHS is down -1.55% year-to-date (YTD) with +$6M in YTD flows. PBE performs worse with -3.89% YTD performance, and +$135K in YTD flows. Run a side-by-side ETF comparison of XHS and PBE below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

XHS vs PBE performance and flow charts

Performance

-4.0-2.00.02.04.0%Feb 10Feb 18Feb 25Mar 4

Cumulative Flows

-8 M-6 M-4 M-2 M0 MFeb 10Feb 18Feb 25Mar 4

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 03/10/2026
1M3MYTD1Y3Y5Y
Perf.
XHS
PBE
-0.71%-3.57%
-2.04%-1.26%
-1.55%-3.89%
+11.15%+20.46%
+26.55%+31.83%
+1.67%+10.46%
Flows
XHS
PBE
-$8M-$3M
+$2M+$969K
+$6M+$135K
-$3M-$32M
-$36M-$56M
-$38M-$39M
Volatility and drawdown
3M1Y3Y5Y
Volatility
XHS
PBE
+17.76%+18.21%
+19.20%+22.16%
+18.15%+20.15%
+21.13%+22.81%
Max drawdown
XHS
PBE
-5.98%-9.23%
-12.54%-16.18%
-17.78%-22.21%
-32.53%-34.74%
Max drawdown duration
XHS
PBE
63d62d
128d107d
362d324d
1716d1540d
Trading data

Create an account to view trading data

Join for free
XHS
PBE
Last sale
3/11/2026 at 1:30 PM
$104.90
$78.26
Previous close
03/10/2026
$105.14
$78.82
Consolidated volume
03/10/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of February 27, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

Create an account to view replication quality

Join for free
XHS
PBE
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 3/11/2026 at 1:30 PM
Live
Closed
XHS
PBE
Last price
$104.90
$78.26
1D performance
-0.23%
-0.71%
AuM$87.35 M$249.34 M
E/R0.35%0.58%
Characteristics
XHS
PBE
Management strategyPassivePassive
ProviderSPDRInvesco
BenchmarkS&P Health Care Services Select Industry IndexDynamic Biotech & Genome Intellidex Index
N° of holdings5230
Asset classEquitiesEquities
Trailing 12m distribution yield
Join
Join
Inception dateSeptember 28, 2011June 23, 2005
ESGNoNo
Advertisement
Exposure

Countries

XHS
USA
99.96%
Other
0.04%
PBE
USA
94.25%
Other
5.75%

Sectors

XHS
Health Care
87.38%
Other
12.62%
PBE
Health Care
96.95%
Other
3.05%
Advertisement

Diversification

XHS

Total weight of top 15 holdings out of 15

33.22%
PBE

Total weight of top 15 holdings out of 15

61.48%

Top 15 holdings

Data as of January 31, 2026
XHS
BROOKDALE SENIOR LIVING
2.87%
ALIGNMENT HEALTHCARE
2.39%
US20603L1026
2.27%
CENTENE
2.25%
MOLINA HLTHCRE
2.24%
US10950A1060
2.24%
GUARDANT HEALTH INC
2.23%
CARDINAL HEALTH
2.17%
AMERISOURCEBERGEN
2.11%
CIGNA
2.09%
HCA HEALTHCARE
2.09%
QUEST DIAGNOSTICS
2.09%
US5049221055
2.08%
OPTION CARE HEALTH INC
2.06%
MCKESSON
2.04%
PBE
ILLUMINA
5.91%
GILEAD SCIENCES
5.35%
AMGEN-T
5.09%
REGENERON PHARMACEUTICALS
4.87%
UTD THERAPEUT
4.83%
BIOGEN INC
4.76%
INCYTE
4.70%
ALNYLAM PHARMACEUTICALS
4.05%
AMICUS THERAPEUTICS
3.83%
DYNAVAX TECHNOLOGIES
3.60%
NL0015002SN0
3.05%
ACADIA PHARMACEUTICALS
2.98%
MANNKIND
2.89%
BIO-TECHNE CORP
2.83%
EXELIXIS
2.74%
Frequently asked questions about XHS and PBE

How have the XHS and PBE ETFs performed in 2026?

As of March 10, 2026, XHS is down -1.55% year-to-date (YTD), while PBE has lost -3.89%. That puts XHS better performer ahead so far this year.

Which ETF is attracting more investor money: XHS or PBE?

Year-to-date, the XHS ETF saw +$6M in flows, compared to +$135K for PBE.

Which ETF is more volatile: XHS or PBE?

Over the past year, XHS had a volatility of 19.2%, while PBE experienced 22.16%.

Which ETF is bigger: XHS or PBE?

As of March 10, 2026, XHS holds $87.35 M in assets under management (AUM), while PBE manages $249.34 M.

What sectors do the XHS and PBE ETFs invest in?

XHS leans toward sectors like Health Care. Meanwhile, PBE focuses on Health Care.

What are the top holdings of the XHS ETF and PBE ETF?

XHS top holdings include BROOKDALE SENIOR LIVING, ALIGNMENT HEALTHCARE and US20603L1026. PBE holds in its top three: ILLUMINA, GILEAD SCIENCES and AMGEN-T.

Which ETF is more diversified: XHS or PBE?

XHS holds 59 securities with 33.22% of its assets in the top 15. PBE has 30 securities and a top 15 weight of 61.48%.

Advertisement
Advertisement
Advertisement
The Active Trader Report

Active Trader Report: Use of Leveraged & Inverse ETFs Way Up

Direxion partnered with Compound Insights and Vanda to explore what’s driving the evolution of active trading — and how active traders are using leveraged and inverse funds across equities, single stocks, commodities, and volatility.

Active Trader Report: Use of Leveraged & Inverse ETFs Way Up